Full article view2017-09-21T08:01:31+00:00

Smith and Richards Recap the FDA's Workshop on Troponin Assays in Regulatory Focus


Precision for Medicine’s Judi Smith and Karen Richards highlight key takeaways from the FDA’s Cardiac Troponin Assays workshop. They review the history, uses, and issues associated with measuring troponin and innovative medical devices to detect troponin levels as an assay to aid in diagnosis.

To read the article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.